These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9585390)

  • 1. Diabetes mellitus and myocardial infarction: a time to act or a time to wait?
    Fisher BM
    Diabet Med; 1998 Apr; 15(4):275. PubMed ID: 9585390
    [No Abstract]   [Full Text] [Related]  

  • 2. Early and often. A glucose control and heart health update.
    Gebel E
    Diabetes Forecast; 2009 Feb; 62(2):54-6. PubMed ID: 19326580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality after myocardial infarction in patients with diabetes mellitus.
    Kapur A; De Palma R
    Heart; 2007 Dec; 93(12):1504-6. PubMed ID: 18003679
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myocardial infarction and disorders of carbohydrate metabolism].
    Janion M; Mareczek S
    Przegl Lek; 1982; 39(12):801-4. PubMed ID: 7167646
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus.
    van der Schaaf RJ; Henriques JP; Wiersma JJ; Koch KT; Baan J; Mulder KJ; Durrer JD; Tijssen JG; Piek JJ; de Winter RJ
    Heart; 2006 Jan; 92(1):117-8. PubMed ID: 15890764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of diabetes mellitus and its complications. 7. Control of blood glucose and diabetic microangiopathy].
    Shichiri M
    Nihon Naika Gakkai Zasshi; 1996 Sep; 85(9):1484-9. PubMed ID: 8999095
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin vs. strict blood glucose control to achieve a survival benefit after AMI?
    Van den Berghe G
    Eur Heart J; 2005 Apr; 26(7):639-41. PubMed ID: 15757955
    [No Abstract]   [Full Text] [Related]  

  • 9. A progress report on the University Group Diabetes Program.
    Prout TE
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
    Stranders I; Diamant M; van Gelder RE; Spruijt HJ; Twisk JW; Heine RJ; Visser FC
    Arch Intern Med; 2004 May; 164(9):982-8. PubMed ID: 15136307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors reduce heart-related death in type 2 diabetics.
    Health News; 2004 Oct; 10(10):15. PubMed ID: 15584126
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose control and diabetic microangiopathy.
    Cheah JS
    Med J Malaysia; 1981 Dec; 36(4):220-6. PubMed ID: 7334957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
    Leschke M
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in diabetic patients.
    Goldberg RB
    Med Clin North Am; 2000 Jan; 84(1):81-93, viii. PubMed ID: 10685129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose, insulin, and coronary heart disease.
    Das UN
    Eur Heart J; 2008 Apr; 29(8):1075-6; author reply 1076-7. PubMed ID: 18353758
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic metabolic control: how important? An appraisal.
    Khardori R; Menon PS
    Indian Pediatr; 1987 Nov; 24(11):965-8. PubMed ID: 3330054
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
    Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
    Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.